(CRBN) Corbion - Ratings and Ratios

Exchange: AS • Country: Netherlands • Currency: EUR • Type: Common Stock • ISIN: NL0010583399

CRBN: Lactic Acid, Derivatives, Enzymes, Minerals, Vitamins, Algae Ingredients

Corbion NV, a company with a rich history dating back to 1919, has established itself as a leading global supplier of innovative ingredient solutions. Its product portfolio includes a wide range of lactic acid and lactic acid derivatives, as well as other fermentation-based products, functional enzyme blends, minerals, vitamins, and algae ingredients. These ingredients cater to various industries, including food, home and personal care, animal nutrition, supplements, pharmaceuticals, medical devices, and bioplastics, providing customers with tailored solutions to meet their specific needs.

The company's extensive network of sales offices and distributors enables it to effectively market its products worldwide, ensuring a strong presence in key markets. This strategic approach allows Corbion NV to stay close to its customers, understand their requirements, and provide them with high-quality products and services. With a strong focus on research and development, the company continuously works to expand its product offerings and improve existing ones, driving growth and innovation in the industries it serves.

Formerly known as CSM NV, the company underwent a significant transformation in 2013, adopting the name Corbion NV in October of that year. This rebranding reflected the company's evolving strategy and commitment to delivering sustainable and innovative solutions to its customers. Headquartered in Amsterdam, the Netherlands, Corbion NV is listed on the Euronext Amsterdam stock exchange under the ticker symbol CRBN, with its common stock traded under the ISIN code NL0010583399. As a specialty chemicals company, Corbion NV operates within the GICS Sub Industry of Specialty Chemicals, further underscoring its focus on developing and marketing high-performance ingredients for a wide range of applications.

Through its website, https://www.corbion.com, Corbion NV provides stakeholders with access to detailed information about its products, services, and sustainability initiatives. With a long history of delivering value to its customers and shareholders, the company remains committed to driving growth, innovation, and sustainability in the industries it serves, while maintaining its position as a leading player in the global specialty chemicals market.

Additional Sources for CRBN Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

CRBN Stock Overview

Market Cap in USD 1,292m
Sector Basic Materials
Industry Specialty Chemicals
GiC Sub-Industry Specialty Chemicals
IPO / Inception

CRBN Stock Ratings

Growth 5y -17.1%
Fundamental 67.7%
Dividend 49.2%
Rel. Strength Industry 332
Analysts -
Fair Price Momentum 23.32 EUR
Fair Price DCF 9.22 EUR

CRBN Dividends

Dividend Yield 12m 3.06%
Yield on Cost 5y 2.66%
Annual Growth 5y 4.86%
Payout Consistency 92.2%

CRBN Growth Ratios

Growth Correlation 3m -54.6%
Growth Correlation 12m 82.1%
Growth Correlation 5y -71.5%
CAGR 5y -2.73%
CAGR/Mean DD 5y -0.08
Sharpe Ratio 12m 0.77
Alpha 6.24
Beta 0.66
Volatility 31.72%
Current Volume 42.8k
Average Volume 20d 72.6k
What is the price of CRBN stocks?
As of January 22, 2025, the stock is trading at EUR 23.22 with a total of 42,810 shares traded.
Over the past week, the price has changed by +4.41%, over one month by +8.10%, over three months by -6.67% and over the past year by +45.14%.
Is Corbion a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Corbion (AS:CRBN) is currently (January 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 67.72 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CRBN as of January 2025 is 23.32. This means that CRBN is currently overvalued and has a potential downside of 0.43%.
Is CRBN a buy, sell or hold?
Corbion has no consensus analysts rating.
What are the forecast for CRBN stock price target?
According to ValueRays Forecast Model, CRBN Corbion will be worth about 25.3 in January 2026. The stock is currently trading at 23.22. This means that the stock has a potential upside of +8.87%.
Issuer Forecast Upside
Wallstreet Target Price 26 12%
Analysts Target Price - -
ValueRay Target Price 25.3 8.9%